Tag: viral gastroenteritis market size

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What Growth Rate is the Viral Gastroenteritis Market Anticipated to Experience from 2024-2033?

In recent times, we have witnessed a substantial growth in the market size of viral gastroenteritis. The expansion will progress from a valuation of $6.34 billion in 2023 to $6.7 billion in 2024, indicating a compound annual growth rate (CAGR) of 5.7%. Factors such as the pervasiveness of viral infections, worldwide hygiene protocols, advancements in diagnostic procedures, global travel and tourism, and climate and environment-related factors contributed to the growth during the historic period.

In the coming years, the market size for viral gastroenteritis is anticipated to experience consistent growth, reaching $8.1 billion by 2028, with a compound annual growth rate (CAGR) of 4.9%. Factors driving growth in the forecast period include global health readiness, effects of climate change, a unified health approach, epidemiological monitoring systems, as well as education and increased public awareness. Key trends anticipated during the forecast period encompass the development of vaccines, advancements in diagnostics, the use of telemedicine for diagnosis, joint research efforts, personalized treatment strategies, and the implementation of digital health solutions.

Claim Your Free Sample of the Global Viral Gastroenteritis Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp

What Are the Significant Influencers of Growth in the viral gastroenteritis Market?

The rise in occurrences of gastrointestinal conditions is predicted to fuel the expansion of the viral gastroenteritis market in the future. Diseases that manifest in or on any segment of the gastrointestinal tract are referred to as gastrointestinal (GI) disorders. Medications and diagnostic treatments for viral gastroenteritis benefit those affected by providing suitable and effective treatment. For example, a survey conducted in October 2021 by Bodibio, an American fitness and wellness firm, spanning 33 nations and involving 73,076 adults, pointed out that 40% of the participants suffered from a functional gastrointestinal disorder. This included all different forms of functional dyspepsia, irritable bowel syndrome, functional constipation, among others. Consequently, the rising incidence of gastrointestinal conditions is propelling the viral gastroenteritis market’s growth.

What Key Segments Define the Viral Gastroenteritis Market?

1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs

2) By Diagnosis: Physical Examination, Rapid Stool Test

3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

What Are the Key Developments Shaping the Viral Gastroenteritis Market?

The viral gastroenteritis market is witnessing a growing trend of product innovation. To solidify their market standing, the leading companies are focusing on launching new products. For example, in November 2022, GlaxoSmithKline plc, a biopharmaceutical company based in the UK, was granted approval by the US Food and Drug Administration (FDA) for its ROTARIX oral-dosing applicator-only presentation (liquid formulation). This is designed to prevent rotavirus gastroenteritis in infants. The formulation means healthcare providers no longer need to reconstitute the vaccine dose when they use it. This approval is based on international clinical trials that showed the safety and tolerability of the formulation compared to the lyophilized version, and that it was not less potent in terms of immunogenicity.

Order Now for Fast Delivery of Your Viral Gastroenteritis Market Report!

https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

What Regions Are Driving Expansion in the Viral Gastroenteritis Market?

North America was the largest region in the viral gastroenteritis market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Viral Gastroenteritis Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the viral gastroenteritis market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Viral Gastroenteritis Market Include

1. Viral Gastroenteritis Market Executive Summary

2. Viral Gastroenteritis Market Segments

3. Viral Gastroenteritis Market Size And Template Market Growth Rate

4. Key Viral Gastroenteritis Market Trends

5. Major Viral Gastroenteritis Market Drivers

……

25. Key Mergers And Acquisitions In The Viral Gastroenteritis Market

26. Top Viral Gastroenteritis Companies

27. Viral Gastroenteritis Market Opportunities And Strategies

28. Viral Gastroenteritis Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Anti-Viral Drug Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth

https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

Viral Vectors And Plasmid DNA Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Antivirals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The viral gastroenteritis market has witnessed robust growth in recent years, with significant projections for the future. The market size surged from $6.34 billion in 2023 to $6.7 billion in 2024, marking a compelling compound annual growth rate (CAGR) of 5.7%. This expansion owes itself to several key factors:

Factors Driving Historic Growth

• Prevalence of Viral Infections: The widespread occurrence of viral infections has necessitated the development of effective treatments and diagnostics.
• Advancements in Diagnostics: Technological innovations have enhanced the accuracy and efficiency of diagnostic procedures.
• Global Travel and Tourism: Increased international travel has contributed to the dissemination of gastrointestinal ailments worldwide.
• Hygiene Practices: Global hygiene initiatives have played a pivotal role in combating viral gastroenteritis.
• Climate and Environmental Factors: Changing environmental conditions have influenced disease patterns, necessitating adaptive healthcare strategies.

View More On The Viral Gastroenteritis Market Report 2024 – https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

Charting the Course Ahead
The forecast for the viral gastroenteritis market remains optimistic, with steady growth anticipated in the coming years. By 2028, the market is projected to reach $8.1 billion, demonstrating a CAGR of 4.9%. Key drivers of growth in the forecast period include:

Factors Fueling Future Growth

• Global Health Preparedness: Heightened awareness and preparedness efforts are expected to bolster market expansion.
• Climate Change Impact: Environmental shifts will likely influence disease prevalence, necessitating proactive healthcare measures.
• Epidemiological Surveillance Systems: Enhanced surveillance capabilities will enable prompt detection and response to outbreaks.
• Education and Public Awareness: Increased awareness about gastrointestinal disorders will drive demand for effective treatments.
• One Health Approach: A holistic approach to healthcare encompassing human, animal, and environmental health will shape disease management strategies.

Emerging Trends and Innovations

In the forecast period, the viral gastroenteritis market is poised to witness transformative trends and innovations, including:

Key Trends

• Vaccine Development: Advancements in vaccine research hold promise for disease prevention.
• Advanced Diagnostics: Innovations in diagnostic technologies will facilitate early detection and treatment.
• Telemedicine in Diagnosis: Remote healthcare services will improve access to diagnosis and treatment.
• Collaborative Research Initiatives: Partnerships between academia, industry, and government will drive innovation and knowledge exchange.
• Personalized Medicine Approaches: Tailored treatment strategies based on individual patient characteristics will optimize therapeutic outcomes.
• Digital Health Solutions: Digital platforms and tools will streamline healthcare delivery and patient management.

Rising Prevalence of Gastrointestinal Disorders to Drive Market Growth

The escalating prevalence of gastrointestinal disorders, encompassing a spectrum of ailments affecting the digestive tract, is a primary driver of market growth. Notably, a survey conducted across 33 countries revealed a significant incidence of functional gastrointestinal disorders among adults. This burgeoning prevalence underscores the demand for effective viral gastroenteritis treatments and diagnostics.

Product Innovations Transforming the Viral Gastroenteritis Market

Product innovation emerges as a pivotal trend shaping the viral gastroenteritis market landscape. Major players are leveraging innovation to fortify their market presence. For instance:

Innovative Developments

• Oral-Dosing Applicator for ROTARIX: GlaxoSmithKline PLC’s approval for an oral-dosing applicator-only presentation of ROTARIX streamlines vaccine administration, enhancing convenience for healthcare providers.
• Diagnostic Expansion Through Acquisition: Hologic Inc.’s acquisition of Diagenode broadens its diagnostic portfolio, enabling expanded diagnostic capabilities across infections, including gastroenteritis.

Segmentation and Regional Insights

The viral gastroenteritis market is segmented based on drugs, diagnosis, indication, type of virus, and end-users. Notably, North America led the market in 2023, with Asia Pacific poised for rapid growth in the forecast period.

In Conclusion

The viral gastroenteritis market presents a dynamic landscape characterized by growth opportunities driven by evolving healthcare needs, technological advancements, and shifting disease patterns. As stakeholders continue to innovate and collaborate, the market is poised for sustained expansion, ensuring enhanced treatment outcomes and patient care on a global scale.

Request A Sample Of The Global Viral Gastroenteritis Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=12127&type=smp